Man Group’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$258K Sell
67,597
-29,236
-30% -$141K ﹤0.01% 2221
2026
Q1
$513K Buy
+96,833
New +$597K ﹤0.01% 2077
2022
Q2
Sell
-975
Closed -$15.5K 1982
2022
Q1
$16K Buy
+975
New +$16.8K ﹤0.01% 2157
2019
Q2
Sell
-41,815
Closed -$1.49M 2018
2019
Q1
$1.49M Sell
41,815
-1,554
-4% -$61.4K 0.01% 1449
2018
Q4
$1.75M Sell
43,369
-18,914
-30% -$1.15M 0.01% 1272
2018
Q3
$5.42M Buy
+62,283
New +$6.19M 0.02% 943
2018
Q2
Sell
-7,549
Closed -$270K 2239
2018
Q1
$270K Buy
+7,549
New +$292K ﹤0.01% 1864

Other funds holding VSTM

Man Group's VSTM Position: Q2 2026 in Review

Man Group reduced its Verastem (VSTM) stake by 30% in Q2 2026, selling an estimated $141K and leaving 67,597 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #2221.

Man Group first reported a position in VSTM in Q1 2018 and has held it in 7 quarters since. The position peaked at $5.42M in Q3 2018. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Man Group held 67,597 shares of Verastem worth $258K as of Q2 2026.
  • Man Group sold 29,236 Verastem shares in Q2 2026, an estimated $141K.
  • Verastem made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #2221 holding.
  • Man Group first reported a position in Verastem in Q1 2018 and has held it in 7 quarters since.
  • Man Group's Verastem position peaked at $5.42M in Q3 2018.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.